ProCE Banner Activity

Managing Elevated LDL-C Levels to Reduce ASCVD Risk: Primary and Secondary Prevention

Slideset Download

Leading experts provide insights on the management of elevated LDL-C levels to reduce ASCVD risk in the primary care setting. Learn about guideline recommendations and treatment options, including nonstatin therapies.

Released: April 05, 2023



Ty J. Gluckman

Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Medical Director
Center for Cardiovascular Analytics, Research, and Data Science (CARDS)
Providence Heart Institute
Providence Health System
Portland, Oregon

Viet Le

Viet Le, DMSc, PA-C, FACC, FAHA, HF-Cert

Associate Professor of Research, Preventive Cardiology PA
Intermountain Heart and Vascular Clinical Program
Intermountain Health, Canyons Region
Salt Lake City, Utah

Erin Michos

Erin Michos, MD, MHS

Director of Women’s Cardiovascular Health Research
Associate Director of Preventive Cardiology
Associate Professor of Medicine & Epidemiology
Division of Cardiology
Johns Hopkins University School of Medicine
Baltimore, MD
Co-Editor in Chief, the American Journal of Preventive Cardiology

Margo B. Minissian

Margo B. Minissian, PhD, ACNP, FAHA, FNLA

Executive Director, Geri and Richard Brawerman Nursing Institute
Simms/ Mann Family Foundation Endowed Chair in Nurse Education,
Innovation and Research
Assistant Professor, Cardiology
Los Angeles, CA

Provided by

ProCE Banner


Supported by an educational grant from

Novartis Pharmaceuticals Corporation


Clinical Care Options, LLC

ProCE Banner